Fibroadenoma interventions

Xyz Microchapters
Home
Patient Information
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Xyz from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
Diagnostic Study of Choice
History and Symptoms
Physical Examination
Laboratory Findings
Electrocardiogram
X-ray
Echocardiography and Ultrasound
CT scan
MRI
Other Imaging Findings
Other Diagnostic Studies
Treatment
Medical Therapy
Interventions
Surgery
Primary Prevention
Secondary Prevention
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Case Studies
Case #1
Fibroadenoma interventions On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Fibroadenoma interventions All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Fibroadenoma interventions
CDC on Fibroadenoma interventions
Fibroadenoma interventions in the news
Blogs on Fibroadenoma interventions
Directions to Hospitals Treating Psoriasis
Risk calculators and risk factors for Fibroadenoma interventions

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Sogand Goudarzi, MD [2]

Overview

There are no recommended therapeutic interventions for the management of [disease name].

OR

[Name of intervention] is not the first-line treatment option for patients with [disease name]. [Name of intervention] is usually reserved for patients with either [indication 1], [indication 2], and [indication 3]

OR

The mainstay of treatment for [disease name] is medical therapy/surgery. [Name of intervention] is usually reserved for patients with either [indication 1], [indication 2], and/or [indication 3].

OR

The feasibility of [name of intervention] depends on the stage of [disease or malignancy] at the time of diagnosis.

OR

[Name of intervention] is the mainstay of treatment for [disease or malignancy].

Indications

Observation

• Most fibroadenomas are managed conservatively with yearly breast examination and ultrasound if necessary. This is related to the fact that about 10 to 40% of fibroadenomas regress spontaneously.
• Reasons to undergo intervention of a fibroadenoma:

• Significant anxiety in a patient (despite knowing that the lesion has a low malignant potential)
• Mass is greater than 5 cm in size
• Rapidly enlarging size
• Intense pain
• Distortion of breast parenchyma
• Cosmetic issues
• Persistent mass with no regression
• Hypercellular stroma on ultrasound
• High malignant potential
• Presence of a high risk genetic mutation or syndrome